Följ
Shona Kalkman
Shona Kalkman
Scientific staff at Gezondheidsraad
Verifierad e-postadress på gr.nl
Titel
Citeras av
Citeras av
År
Patients’ and public views and attitudes towards the sharing of health data for research: a narrative review of the empirical evidence
S Kalkman, J Van Delden, A Banerjee, B Tyl, M Mostert, G Van Thiel
Journal of medical ethics 48 (1), 3-13, 2022
2092022
Responsible data sharing in international health research: a systematic review of principles and norms
S Kalkman, M Mostert, C Gerlinger, JJM van Delden, GJMW van Thiel
BMC medical ethics 20, 1-13, 2019
1232019
Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences
KO Rengerink, S Kalkman, S Collier, A Ciaglia, SD Worsley, ...
Journal of clinical epidemiology 89, 173-180, 2017
862017
Community-based healthcare for migrants and refugees: a scoping literature review of best practices
E Riza, S Kalkman, A Coritsidis, S Koubardas, S Vassiliu, D Lazarou, ...
Healthcare 8 (2), 115, 2020
432020
Series: Pragmatic trials and real world evidence: Paper 4. Informed consent
S Kalkman, GJMW van Thiel, MGP Zuidgeest, I Goetz, BM Pfeiffer, ...
Journal of clinical epidemiology 89, 181-187, 2017
42*2017
The social licence for data-intensive health research: towards co-creation, public value and trust
SHA Muller, S Kalkman, GJMW van Thiel, M Mostert, JJM van Delden
BMC Medical Ethics 22 (1), 110, 2021
402021
The effects of under 6 hours of formalin fixation on hormone receptor and HER2 expression in invasive breast cancer: a systematic review
S Kalkman, MW Barentsz, PJ Van Diest
American Journal of Clinical Pathology 142 (1), 16-22, 2014
342014
Survival after perioperative cardiopulmonary resuscitation: providing an evidence base for ethical management of do-not-resuscitate orders
S Kalkman, L Hooft, JM Meijerman, JTA Knape, JJM van Delden
Anesthesiology 124 (3), 723-729, 2016
302016
Responsible data sharing in a big data-driven translational research platform: lessons learned
S Kalkman, M Mostert, N Udo-Beauvisage, JJ Van Delden, GJ Van Thiel
BMC Medical Informatics and Decision Making 19 (1), 283, 2019
292019
Pragmatic randomized trials in drug development pose new ethical questions: a systematic review
S Kalkman, GJMW van Thiel, DE Grobbee, JJM van Delden
Drug discovery today 20 (7), 856-862, 2015
222015
Stakeholders’ views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs
S Kalkman, GJMW van Thiel, DE Grobbee, AK Meinecke, MGP Zuidgeest, ...
Trials 17, 1-8, 2016
202016
The social value of pragmatic trials
S Kalkman, G Van Thiel, R Van Der Graaf, M Zuidgeest, I Goetz, ...
Bioethics 31 (2), 136-143, 2017
182017
Brief fixation does not affect assessment of hormone receptor expression in invasive breast carcinoma biopsies: paving the road for same-day tissue diagnostics
S Kalkman, MW Barentsz, AJ Witkamp, E Van Der Wall, HM Verkooijen, ...
The American journal of surgical pathology 38 (8), 1071-1078, 2014
182014
Ethics of informed consent for pragmatic trials with new interventions
S Kalkman, SYH Kim, GJMW van Thiel, DE Grobbee, JJM van Delden
Value in Health 20 (7), 902-908, 2017
172017
Brief fixation does not hamper the reliability of Ki67 analysis in breast cancer core‐needle biopsies: a double‐centre study
S Kalkman, JP Bulte, A Halilovic, P Bult, PJ van Diest
Histopathology 66 (3), 380-387, 2015
122015
Delden J van, Banerjee A, Tyl B, Mostert M, Thiel G van. Patients’ and public views and attitudes towards the sharing of health data for research: a narrative review of the …
S Kalkman
J Med Ethics [Internet], 2019
72019
Assessment of HER 2 status in breast cancer biopsies is not affected by accelerated tissue processing
JP Bulte, A Halilovic, S Kalkman, PHJ van Cleef, PJ van Diest, ...
Histopathology 73 (1), 81-89, 2018
72018
Context-relative norms determine the appropriate type of Consent in Clinical Biobanks: towards a potential solution for the discrepancy between the General Data Protection …
R Indrakusuma, S Kalkman, MJW Koelemay, R Balm, DL Willems
Science and engineering ethics 26, 3271-3284, 2020
62020
In-hospital production of medicines: preparing for disruption
S Kalkman, M Arentshorst, J Hoekman, W Boon, E Uijtendaal, G van Thiel, ...
Trends in biotechnology 38 (10), 1045-1047, 2020
52020
The case for screening in early life for ‘non-treatable’disorders: ethics, evidence and proportionality. A report from the Health Council of the Netherlands
S Kalkman, W Dondorp
European Journal of Human Genetics 30 (10), 1155-1158, 2022
42022
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20